Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Citroma

Last content change checked dailysee data sync status

Active ingredient
Magnesium Citrate 1.745 g/29.6 mL
Other brand names
Drug classes
Calculi Dissolution Agent, Osmotic Laxative
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2021
Label revision date
March 12, 2026
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Magnesium Citrate 1.745 g/29.6 mL
Other brand names
Drug classes
Calculi Dissolution Agent, Osmotic Laxative
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2021
Label revision date
March 12, 2026
Manufacturer
Vi-Jon, LLC
Registration number
M007
NDC root
0869-0162
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Magnesium Citrate is a saline laxative that comes in an oral solution, typically flavored with grape. It is designed to help relieve occasional constipation (irregularity) by drawing water into the intestines, which helps to stimulate a bowel movement. You can expect it to generally produce results within half an hour to six hours after taking it.

This product is low in sodium and is blended in the USA, making it a convenient option for those seeking relief from constipation.

Uses

If you're experiencing occasional constipation (irregularity), this medication can help provide relief. It works by stimulating your bowels, typically resulting in a bowel movement within 1/2 to 6 hours after taking it. This can be particularly useful if you're looking for a quick solution to get things moving again.

Rest assured, there are no known teratogenic effects (harmful effects on fetal development) or nonteratogenic effects associated with this medication, making it a safe option for those in need of relief from constipation.

Dosage and Administration

Before you take this medication, make sure to shake the bottle well. When you're ready to take your dose, drink a full glass (8 ounces) of liquid along with it. You can take this medication either as a single dose each day or split it into smaller doses throughout the day.

For adults and children aged 12 and older, the recommended amount is between 6.5 to 10 fluid ounces within a 24-hour period. If your child is between 6 and 12 years old, they should have between 3 to 7 fluid ounces, but not more than 7 fluid ounces in a day. For younger children aged 2 to under 6 years, the limit is 2 to 3 fluid ounces in 24 hours. If your child is under 2 years old, it's best to consult a doctor before giving them this medication.

What to Avoid

It's important to be aware of certain situations when using this medication. You should stop using it and consult your doctor if you experience rectal bleeding or if you do not have a bowel movement after using it. These symptoms could indicate a more serious health issue that needs attention.

Currently, there are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with this medication. However, always prioritize your health and safety by following the guidance provided by your healthcare professional.

Side Effects

If you experience rectal bleeding or do not have a bowel movement after using this medication, it is important to stop using it and consult your doctor. These symptoms could indicate a serious condition that requires medical attention. Always prioritize your health and seek guidance if you have any concerns.

Warnings and Precautions

Before using this product, it's important to consider your health conditions. You should consult your doctor if you have kidney disease, are on a magnesium-restricted diet, experience abdominal pain, nausea, or vomiting, notice a sudden change in your bowel habits that lasts for two weeks, or have been using a laxative for more than one week.

If you accidentally take too much of this product, seek emergency medical help or contact a Poison Control Center immediately. Additionally, if you experience rectal bleeding or do not have a bowel movement after using the product, stop taking it and call your doctor, as these could indicate a serious health issue.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it is crucial to seek immediate medical help.

In case of an emergency, call your local emergency number or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with your healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize open communication with your doctor regarding any medications you may be considering during this time.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with your healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

When it comes to giving this medication to children, it's important to follow the recommended dosages based on their age. For children aged 12 years and older, the maximum amount is between 6.5 to 10 fluid ounces in a 24-hour period. If your child is between 6 and 12 years old, they should not exceed 7 fluid ounces in a day. For younger children aged 2 to under 6 years, the limit is 2 to 3 fluid ounces within 24 hours.

If your child is under 2 years old, it's crucial to consult a doctor before administering this medication. Always ensure you adhere to these guidelines to keep your child safe and healthy.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. This is because renal impairment (reduced kidney function) can affect how your body processes certain drugs. To ensure your safety, your healthcare provider will monitor your creatinine clearance (a test that measures how well your kidneys are filtering waste) regularly.

Additionally, regular renal function tests are essential to keep track of your kidney health. If you have significant renal impairment, special monitoring will be necessary to manage your treatment effectively. Always communicate with your healthcare team about your kidney function to ensure the best care.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (issues with liver function).

Always consult your healthcare provider for personalized advice and to discuss any concerns regarding your liver health and how it may relate to your treatment. They can help ensure that you receive the safest and most effective care.

Drug Interactions

It's important to be aware that certain medications can interact with each other, which may affect how well they work. For example, if you are taking laxatives like magnesium citrate, it's recommended to take them at least 2 hours before or after other medications. This helps ensure that the laxative does not interfere with the effectiveness of your other drugs.

Always discuss any medications you are taking with your healthcare provider. They can help you understand potential interactions and ensure that your treatment plan is safe and effective.

Storage and Handling

To ensure the best performance and safety of your product, store it at temperatures between 46° and 86°F (8° and 30°C). This temperature range helps maintain the integrity of the device.

When handling the product, be sure to do so with clean hands and in a clean environment to avoid contamination. Always follow any specific disposal instructions provided to ensure safe and responsible disposal of any components.

Additional Information

No further information is available.

FAQ

What is Magnesium Citrate?

Magnesium Citrate is a saline laxative in an oral solution form, designed for the relief of occasional constipation.

How does Magnesium Citrate work?

It generally produces a bowel movement within 1/2 to 6 hours after ingestion.

What is the recommended dosage for adults and children over 12?

Adults and children 12 years and older can take 6.5 to 10 fl oz in 24 hours.

What should children aged 6 to under 12 take?

Children aged 6 to under 12 years can take 3 to 7 fl oz, with a maximum of 7 fl oz in 24 hours.

Is Magnesium Citrate safe for children under 2?

For children under 2 years of age, you should ask a doctor before use.

What precautions should I take before using Magnesium Citrate?

Consult a doctor if you have kidney disease, a magnesium-restricted diet, abdominal pain, nausea, vomiting, or a sudden change in bowel habits lasting over 2 weeks.

What should I do if I experience rectal bleeding?

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use, as these could indicate a serious condition.

Can I take Magnesium Citrate if I am pregnant or breastfeeding?

You should ask a health professional before using Magnesium Citrate if you are pregnant or breastfeeding.

How should I store Magnesium Citrate?

Store Magnesium Citrate at temperatures between 46° and 86°F (8° and 30°C).

Are there any drug interactions with Magnesium Citrate?

Laxatives like Magnesium Citrate may affect how other drugs work; take it 2 or more hours before or after other medications.

Packaging Info

Below are the non-prescription pack sizes of Citroma (magnesium citrate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Citroma.
Details

Drug Information (PDF)

This file contains official product information for Citroma, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within 0.5 to 6 hours of administration.

There are no teratogenic or nonteratogenic effects mentioned in the available data.

Dosage and Administration

The medication should be shaken well before use. It is recommended that patients drink a full glass (8 ounces) of liquid with each dose to ensure proper administration.

For adults and children aged 12 years and older, the dosage ranges from 6.5 to 10 fluid ounces within a 24-hour period. This can be administered as a single daily dose or divided into multiple doses throughout the day.

For children aged 6 to under 12 years, the recommended dosage is between 3 to 7 fluid ounces, with a maximum limit of 7 fluid ounces in a 24-hour period.

For children aged 2 to under 6 years, the dosage should be between 2 to 3 fluid ounces within a 24-hour period.

For children under 2 years of age, it is advised to consult a physician for appropriate dosing recommendations.

Contraindications

Use is contraindicated in patients experiencing rectal bleeding or failure to have a bowel movement after use, as these symptoms may indicate a serious underlying condition. In such cases, it is essential to discontinue use and consult a healthcare professional.

Warnings and Precautions

Patients should be aware of specific warnings associated with this product. It is crucial to consult a healthcare professional prior to use if any of the following conditions are present: kidney disease, a magnesium-restricted diet, abdominal pain, nausea, or vomiting. Additionally, individuals who have experienced a sudden change in bowel habits persisting for more than two weeks or who have used a laxative for longer than one week should seek medical advice before proceeding with this product.

In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients are advised to discontinue use and consult a healthcare provider if they experience rectal bleeding or failure to have a bowel movement after using the product, as these symptoms may indicate a serious underlying condition.

No specific laboratory tests are recommended for monitoring during the use of this product.

Side Effects

Patients should discontinue use and consult a healthcare professional if they experience rectal bleeding or failure to have a bowel movement after use, as these symptoms may indicate a serious underlying condition.

Drug Interactions

Laxatives, particularly magnesium citrate, may influence the efficacy of concomitantly administered medications. It is recommended that magnesium citrate be taken at least 2 hours before or after other drugs to minimize potential interactions.

Currently, there is no available information regarding other drug interactions or interactions with laboratory tests. Therefore, healthcare professionals should remain vigilant and monitor patients for any unexpected effects when these agents are used together.

Packaging & NDC

Below are the non-prescription pack sizes of Citroma (magnesium citrate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Citroma.
Details

Pediatric Use

Pediatric patients aged 12 years and older may receive a dosage of 6.5 to 10 fluid ounces within a 24-hour period. For children aged 6 to under 12 years, the maximum dosage is 7 fluid ounces in 24 hours, with a recommended range of 3 to 7 fluid ounces. In children aged 2 to under 6 years, the dosage is limited to 2 to 3 fluid ounces in 24 hours. For infants and children under 2 years of age, it is advised to consult a doctor before administration.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to seek medical advice prior to use to ensure appropriate risk assessment and management.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering the use of this medication during lactation.

Renal Impairment

Patients with renal impairment may necessitate dosage adjustments based on their level of kidney function. It is essential for healthcare professionals to monitor creatinine clearance in patients with reduced renal function to ensure appropriate dosing. Regular renal function tests should be performed to assess kidney health and detect any changes that may impact treatment. Additionally, special monitoring is required for patients with significant renal impairment to mitigate potential risks associated with medication use.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient's characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or a medical toxicologist may also be beneficial in managing the case effectively.

It is crucial to document all findings and interventions in the patient's medical record to ensure continuity of care and facilitate further management.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is important for patients to be aware of the signs that warrant discontinuation of the product; they should stop use and consult a doctor if they experience rectal bleeding or fail to have a bowel movement after use, as these symptoms may indicate a serious condition.

Prior to using the product, healthcare providers should recommend that patients consult with a doctor if they have any of the following conditions: kidney disease, a magnesium-restricted diet, abdominal pain, nausea, or vomiting. Patients should also be advised to seek medical advice if they have noticed a sudden change in bowel habits that persists for more than two weeks or if they have been using a laxative for longer than one week.

Additionally, healthcare providers should instruct patients to discuss any other medications they are currently taking with their doctor or pharmacist before use. It is crucial to inform patients that this product should be taken at least two hours before or after other medications, as laxatives may influence the effectiveness of other drugs.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 46° to 86°F (8° to 30°C) to maintain its integrity and efficacy. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature range to prevent degradation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Citroma, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Citroma, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.